The use of erythropoietin and magnesium sulphate for the management of hypoxic-ischaemic encephalopathy in Lagos, Nigeria: A randomized control trial

Background: Therapeutic hypothermia is the recommended treatment for moderate-to-severe hypoxic-ischemic encephalopathy (HIE) in newborns. It is not readily available in low- and middle-income countries. Newer promising interventions include erythropoietin (EPO) and magnesium sulfate (MgSO4). This s...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Beatrice Nkolika Ezenwa, Iretiola Bamikeolu Fajolu, Gbenga Olorunfemi, Olaolu Aziza Moronkola, Zainab Opoola, Olanike Olutekunbi, Ann A. Ogbenna, Omodele Olowoyeye, Edem S. Duke, Nimota Adeyemo, Chinyere V. Ezeaka
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2025-04-01
Serie:	Journal of Clinical Sciences
Soggetti:	erythropoietin hypoxic-ischemic encephalopathy magnesium sulfate nigeria outcome randomized control trial
Accesso online:	https://journals.lww.com/10.4103/jcls.jcls_82_24
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!